Drugs / MBRC-201
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07145255 | Sep 2025 → Sep 2029 expected | breast cancer, castration-resistant prostate carcinoma, colorectal cancer, non-small cell lung carcinoma +1 | MBrace Therapeutics | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MBRC-201 | “MBRC-201 ADC” NCT07145255 ↗ |